Hi, I'm Laurie and am talking with U of Washington people regarding the possibility of a new clinical trial just starting in Seattle for HER-2+ patients that have been maximally treated and not achieved a complete remission. It combines "administering escalating doses of ex vivo expanded HER2 specific T cells after in vivo priming with a HER2 specific vaccine." Discussing with my onc in Orlando Wed am and gathering more info. Any input re responses to the vaccine and experience in Seattle would be appreciated. My e-mail address is
tobiah@earthlink.net. Been